| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D
1 company
Lenz Robert A. is a Head Of R&D at Neumora Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $566K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | Head Of R&D | Sell | 5,614 | $1.67 | $9,383.24 | -1.8% | -60.1% | +107.5% | |
| Oct 10, 2024 | NMRA Neumora Therapeutics, Inc. | Head Of R&D | Sell | 13,823 | $15.06 | $208,110.23 | -2.1% | -84.6% | -87.7% | |
| Sep 18, 2024 | NMRA Neumora Therapeutics, Inc. | Head Of R&D | Sell | 41,464 | $11.89 | $492,826.58 | -5.8% | -11.0% | -87.1% | |
| Sep 12, 2024 | NMRA Neumora Therapeutics, Inc. | Head Of R&D | Sell | 32,948 | $11.43 | $376,664.83 | -8.2% | -11.1% | -86.3% |